427 related articles for article (PubMed ID: 25001343)
1. Adherence to clotting factors among persons with hemophilia A or B.
Armstrong EP; Malone DC; Krishnan S; Wessler MJ
Hematology; 2015 Apr; 20(3):148-53. PubMed ID: 25001343
[TBL] [Abstract][Full Text] [Related]
2. Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.
Zhao H; Yang L; Long C; Guo Y; Wu R; Liu X; Qin X; Liang H; Duan Z
Expert Rev Hematol; 2015 Aug; 8(4):543-50. PubMed ID: 25948487
[TBL] [Abstract][Full Text] [Related]
3. Current issues in prophylactic therapy for persons with hemophilia.
Dunn AL; Abshire TC
Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
[TBL] [Abstract][Full Text] [Related]
4. Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.
Clausen N; Petrini P; Claeyssens-Donadel S; Gouw SC; Liesner R;
Haemophilia; 2014 Nov; 20(6):747-55. PubMed ID: 24893572
[TBL] [Abstract][Full Text] [Related]
5. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis in children with haemophilia - the Polish experience.
Klukowska A; Urasinski T; Janik-Moszant A; Bobrowska H; Balwierz W; Woznica-Karczmarz I; Dobaczewski G; Wlazlowski M; Koltan A; Badowska W; Dakowicz L; Karolczyk G; Kostrzewska M; Korczowski B; Wasinski D; Pietrys D; Laguna P; Wysocka M
Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
[No Abstract] [Full Text] [Related]
7. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting.
Ay C; Perschy L; Rejtö J; Kaider A; Pabinger I
Ann Hematol; 2020 Dec; 99(12):2763-2771. PubMed ID: 32918114
[TBL] [Abstract][Full Text] [Related]
8. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.
Pérez-Robles T; Romero-Garrido JA; Rodriguez-Merchan EC; Herrero-Ambrosio A
Thromb Res; 2016 Jul; 143():22-7. PubMed ID: 27172834
[TBL] [Abstract][Full Text] [Related]
9. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
Berntorp E
Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
[TBL] [Abstract][Full Text] [Related]
10. Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ
Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
[TBL] [Abstract][Full Text] [Related]
11. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
[TBL] [Abstract][Full Text] [Related]
12. Hemophilia-associated AIDS in the United States, 1981 to September 1987.
Stehr-Green JK; Holman RC; Jason JM; Evatt BL
Am J Public Health; 1988 Apr; 78(4):439-42. PubMed ID: 3126675
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia.
Kashyap R; Choudhry VP
Indian Pediatr; 2000 Jan; 37(1):45-53. PubMed ID: 10745388
[No Abstract] [Full Text] [Related]
14. Costs and utilization of hemophilia A and B patients with and without inhibitors.
Armstrong EP; Malone DC; Krishnan S; Wessler MJ
J Med Econ; 2014 Nov; 17(11):798-802. PubMed ID: 25111634
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.
Owaidah T; Momen AA; Alzahrani H; Almusa A; Alkasim F; Tarawah A; Nouno RA; Batniji FA; Alothman F; Alomari A; Abu-Herbish S; Abu-Riash M; Siddiqui K; Ahmed M; Mohamed SY; Saleh M
Medicine (Baltimore); 2017 Jan; 96(2):e5456. PubMed ID: 28079788
[TBL] [Abstract][Full Text] [Related]
16. Importance of pharmacokinetics in the management of hemophilia.
Barnes C
Pediatr Blood Cancer; 2013; 60 Suppl 1():S27-9. PubMed ID: 23109436
[TBL] [Abstract][Full Text] [Related]
17. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
Dodd C; Watts RG
Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic factor replacement in hemophilia.
Carcao MD; Aledort L
Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan.
Tu TC; Liou WS; Chou TY; Lin TK; Lee CF; Chen JD; Cham TM; Chung MI
Yonsei Med J; 2013 Jan; 54(1):71-80. PubMed ID: 23225801
[TBL] [Abstract][Full Text] [Related]
20. An objective method for assessing adherence to prophylaxis in adults with severe haemophilia.
Ho S; Gue D; McIntosh K; Bucevska M; Yang M; Jackson S
Haemophilia; 2014 Jan; 20(1):39-43. PubMed ID: 23919911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
